Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,021,000 | 3,799,000 | 1,523,000 | 4,807,000 | 3,873,000 |
| Depreciation Amortization | 864,000 | 556,000 | 270,000 | 1,133,000 | 887,000 |
| Income taxes - deferred | -102,000 | 60,000 | 57,000 | 81,000 | -29,000 |
| Accounts receivable | -845,000 | -313,000 | -639,000 | -1,053,000 | -880,000 |
| Accounts payable and accrued liabilities | 1,624,000 | 1,024,000 | 692,000 | 1,826,000 | 1,394,000 |
| Other Working Capital | 1,860,000 | 3,424,000 | 517,000 | -94,000 | -133,000 |
| Other Operating Activity | -547,000 | -525,000 | 95,000 | -639,000 | -378,000 |
| Operating Cash Flow | $6,875,000 | $8,025,000 | $2,515,000 | $6,061,000 | $4,734,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -668,000 | -764,000 | -77,000 | 254,000 | 139,000 |
| PPE Investments | -743,000 | -437,000 | -204,000 | -1,077,000 | -726,000 |
| Net Acquisitions | -1,973,000 | -1,906,000 | -1,908,000 | N/A | N/A |
| Purchase Of Investment | -16,708,000 | -11,135,000 | -3,896,000 | -22,954,000 | -17,310,000 |
| Sale Of Investment | 12,502,000 | 6,560,000 | 3,325,000 | 21,035,000 | 14,415,000 |
| Other Investing Activity | -39,000 | -36,000 | -24,000 | -50,000 | -33,000 |
| Investing Cash Flow | $-7,629,000 | $-7,718,000 | $-2,784,000 | $-2,792,000 | $-3,515,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,638,000 | 1,584,000 | 1,152,000 | 7,336,000 | 6,341,000 |
| Debt Issued | 2,485,000 | 2,084,000 | 1,205,000 | 2,176,000 | 2,473,000 |
| Debt Repayment | -1,364,000 | -155,000 | -52,000 | -9,158,000 | -1,120,000 |
| Common Stock Issued | 112,000 | 92,000 | 44,000 | 187,000 | 137,000 |
| Common Stock Repurchased | -1,342,000 | -584,000 | -529,000 | -1,701,000 | -1,396,000 |
| Dividend Paid | -720,000 | -482,000 | -240,000 | -818,000 | -616,000 |
| Other Financing Activity | -1,009,000 | -1,755,000 | -901,000 | -288,000 | -6,781,000 |
| Financing Cash Flow | $-200,000 | $784,000 | $679,000 | $-2,266,000 | $-962,000 |
| Exchange Rate Effect | 1,000 | 0 | -2,000 | N/A | -1,000 |
| Beginning Cash Position | 4,937,000 | 4,937,000 | 4,937,000 | 3,934,000 | 3,934,000 |
| End Cash Position | 3,984,000 | 6,028,000 | 5,345,000 | 4,937,000 | 4,190,000 |
| Net Cash Flow | $-953,000 | $1,091,000 | $408,000 | $1,003,000 | $256,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,875,000 | 8,025,000 | 2,515,000 | 6,061,000 | 4,734,000 |
| Capital Expenditure | -743,000 | -437,000 | -204,000 | -1,077,000 | -726,000 |
| Free Cash Flow | 6,132,000 | 7,588,000 | 2,311,000 | 4,984,000 | 4,008,000 |